Purpose
This award provides funding support for experienced researchers with recognized productivity – either within or outside the eczema field – to conduct highly innovative, cutting-edge investigations related to eczema. Data from this award can then be used to seek additional, larger-scale funding from the National Institutes of Health (NIH) or other funding entities to build on these discoveries.
Champion Research Grants facilitate trail-blazing research by established investigators who have built a life-long career in eczema research, as well as thought leaders from other areas of study that can bring additional new perspectives to the research forefront.
This award also serves as a bridge for previous successful NEA Research Award recipients by providing a funding mechanism to stay in the eczema research field and strengthen their research program and commitment to advancing our understanding of this serious disease.
Proposals should address at least one of the following research priorities:
Number of Awards
This is a 1-year grant with the option to undergo a competitive renewal for a second year of funding. Awards are contingent on the receipt of sufficiently meritorious applications. Number of awards annually is at NEA’s discretion
Budget
Applicants may request up to $100,000 (USD; direct costs only). Indirect costs are not allowed on NEA research awards.Salary/fringe benefit support should be commensurate with the percent effort dedicated to the project, using the current allowable NIH salary cap. Additional research staff support should also be commensurate with project percent effort and is unrestricted, with the exception of research fellows which is limited to 50% effort.
NEA funds projects that address its core research priorities, including:
Applications clearly linked to these priorities consistently align best with NEA funding objectives.
NEA places substantial emphasis on improving the lives of people living with eczema.
Highly competitive proposals often address:
Many funded projects focus directly on outcomes that matter to patients and families.
Successful applications typically demonstrate:
NEA repeatedly highlights support for "creative scientific ideas" and innovative research approaches.
NEA offers different grants for different investigator stages:
Applications that fit the purpose of the chosen mechanism tend to be more successful.
NEA funds both basic and clinical science but strongly values research that may ultimately lead to:
Projects that bridge laboratory findings and clinical application are often well received.
For Engagement and Catalyst grants, NEA specifically aims to develop the next generation of eczema researchers.
Successful early-career applicants often demonstrate:
Competitive applications generally include:
Feasibility remains important across all grant categories.
NEA has increasingly emphasized research that reflects patient experiences and priorities.
Examples include:
Patient-centered outcomes research has been highlighted in recent NEA funding programs.
A notable characteristic of NEA-funded investigators is their ability to obtain larger grants after receiving NEA support.
NEA reports that more than one-third of awardees subsequently received NIH funding, making future funding potential an important implicit success factor.
Successful applications often come from institutions with:
Institutional support increases confidence in successful project completion.
Recent NEA-funded projects have focused on:
A highly competitive NEA application typically includes:
Associate Professors and above that have or have had national-level funding as a principal investigator (or Co-PI) within the past 5 years on an R01 grant or its equivalent (e.g. VA Merit Award, NSF grant, NIH program project or cooperative grant).
Previous recipients of NEA Research Grants are also eligible to apply provided the following criteria are met:
The principal investigator must be personally and actively responsible for the conduct of the proposed research and eligible to apply for research grants under the guidelines of the applicant’s host institution. The principal investigator need not be a United States citizen and the research need not take place in the United States.
Sponsor Institute/Organizations: National Eczema Association
Sponsor Type: Corporate/Non-Profit
Address: 505 San Marin Drive, Suite B300, Novato, CA 94945
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Aug 14, 2026
Aug 14, 2026
$100,000
Affiliation: National Eczema Association
Address: 505 San Marin Drive, Suite B300, Novato, CA 94945
Website URL: https://nationaleczema.org/grant-details/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.